• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫复合物溶解:抗原抗体比例的影响以及替代补体途径和经典补体途径的相对作用

Immune-complexes solubilization: effect of antigen-antibody ratio and relative role of alternative and classical complement pathways.

作者信息

Genin C, Lesavre P

出版信息

Mol Immunol. 1983 Oct;20(10):1069-72. doi: 10.1016/0161-5890(83)90114-1.

DOI:10.1016/0161-5890(83)90114-1
PMID:6674809
Abstract

Insoluble immune-complexes (IC) are solubilized by complement. A functional alternative pathway (AP) is required for solubilization. Classical pathway (CP) has an enhancing effect, but the effect of antigen-antibody (Ag-Ab) ratio and the relative role of AP and CP at these different Ag-Ab ratios is controversial. We reinvestigated these factors in a human model (IC prepared with tetanus toxoid and affinity purified human Ab solubilized by normal serum--NHS). We present evidence that (1) IC prepared at Ag excess are only partially solubilized. (2) IC prepared at large Ag excess are not solubilized by AP. (3) AP prepared at Ab excess are solubilized exclusively by AP. (4) IC prepared at equivalence are solubilized by AP and CP acting in synergy.

摘要

不溶性免疫复合物(IC)可被补体溶解。溶解需要功能性替代途径(AP)。经典途径(CP)有增强作用,但抗原抗体(Ag-Ab)比例的影响以及在这些不同Ag-Ab比例下AP和CP的相对作用存在争议。我们在一个人体模型中重新研究了这些因素(用破伤风类毒素和经亲和纯化的人抗体制备的IC,由正常血清——NHS溶解)。我们提供的证据表明:(1)在抗原过量时制备的IC仅部分溶解。(2)在大量抗原过量时制备的IC不能被AP溶解。(3)在抗体过量时制备的IC仅由AP溶解。(4)在等价时制备的IC通过AP和CP协同作用而溶解。

相似文献

1
Immune-complexes solubilization: effect of antigen-antibody ratio and relative role of alternative and classical complement pathways.免疫复合物溶解:抗原抗体比例的影响以及替代补体途径和经典补体途径的相对作用
Mol Immunol. 1983 Oct;20(10):1069-72. doi: 10.1016/0161-5890(83)90114-1.
2
The effects of immunoglobulin isotype and antibody affinity on complement-mediated inhibition of immune precipitation and solubilization.免疫球蛋白同种型和抗体亲和力对补体介导的免疫沉淀抑制及溶解作用的影响。
Mol Immunol. 1987 Nov;24(11):1211-7. doi: 10.1016/0161-5890(87)90168-4.
3
The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.经典途径成分在替代途径调节的免疫复合物聚集中的作用:C1抑制物的作用。
Behring Inst Mitt. 1984 Nov(76):29-41.
4
Activation of the alternative complement pathway by the immune precipitate formed with F(ab')2 fragment of human IgG antibody.人IgG抗体F(ab')2片段形成的免疫沉淀物激活替代补体途径。
Mol Immunol. 1983 Nov;20(11):1221-6. doi: 10.1016/0161-5890(83)90146-3.
5
Binding and activation of the first complement component by soluble immune complexes: effect of complex size and composition.可溶性免疫复合物对补体第一成分的结合与激活:复合物大小和组成的影响
Scand J Immunol. 1984 Feb;19(2):99-110. doi: 10.1111/j.1365-3083.1984.tb00905.x.
6
Characterization of the soluble immune complexes that are detected by three different techniques.通过三种不同技术检测到的可溶性免疫复合物的特性
Clin Immunol Immunopathol. 1986 Feb;38(2):244-55. doi: 10.1016/0090-1229(86)90142-x.
7
Activation of rat complement by soluble and insoluble rat IgA immune complexes.可溶性和不溶性大鼠IgA免疫复合物对大鼠补体的激活作用。
Eur J Immunol. 1988 Dec;18(12):1873-80. doi: 10.1002/eji.1830181202.
8
The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.抗体同种型和抗原表位密度对免疫复合物补体固定活性的影响:一项使用具有人Fc区的嵌合抗NIP抗体的系统研究。
Clin Exp Immunol. 1991 Apr;84(1):1-8. doi: 10.1111/j.1365-2249.1991.tb08115.x.
9
Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans.破伤风类毒素-抗破伤风类毒素复合物:一种研究人类免疫复合物补体转运系统的潜在模型。
Clin Exp Immunol. 1987 Aug;69(2):468-76.
10
Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.免疫沉淀物溶解过程中C3与抗原-抗体复合物的相互作用。
J Immunol. 1984 May;132(5):2531-7.